Dermatological complications of continuous subcutaneous insulin infusion in children and adolescents

The Journal of Pediatrics
Louise S ConwellDenis Daneman

Abstract

To describe the dermatological changes associated with continuous subcutaneous insulin infusion (CSII) therapy in youth with type 1 diabetes mellitus (T1D). To assess their association with duration of CSII, age, adiposity, HbA1(c), insulin dose, insulin brand, infusion set or site. We conducted a cross-sectional study of 50 consecutive patients with T1D who were using CSII for >6 months (26 female; age, 13.3 +/- 3.5 years [mean +/- SD]; CSII duration, 2.8 +/- 1.7 years; HbA1(c), 7.7% +/- 1.1%). A grading scale was devised. Ultrasound scanning was performed in 8 subjects. The mean (+/-SD) severity score was 6.3 +/- 3.5 (range, 0-14; maximum possible, 69). Most common were scars <3 mm diameter (94%), erythema not associated with nodules (66%), subcutaneous nodules (62%), and lipohypertrophy (42%). There was a significant negative correlation between severity score and body mass index z-score (r = -0.3, P = .039), but no correlation with HbA1(c), insulin brand or site. Infusion sets inserted at 90 degrees were associated with lower scores (P = .03). Less than 5% of patients and parents considered stopping CSII because of skin concerns. Ultrasound scanning results of CSII sites revealed mild increased echogenicity of the dermis an...Continue Reading

References

Feb 9, 1984·The New England Journal of Medicine·S M TeutschJ M Lane
Jul 1, 1993·Diabetic Medicine : a Journal of the British Diabetic Association·E ChantelauA A Starke
Sep 30, 1993·The New England Journal of Medicine·UNKNOWN Diabetes Control and Complications Trial Research GroupC Siebert
Aug 16, 2002·American Journal of Clinical Dermatology·Linda García Hidalgo
Oct 23, 2003·JAMA : the Journal of the American Medical Association·UNKNOWN Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Resea
Oct 12, 2004·Clinics in Dermatology·Noah S Scheinfeld
Dec 17, 2004·Pediatric Diabetes·Kupper A WintergerstHelen Y Hsiang
Feb 23, 2005·Archives of Dermatology·Monika-Hildegard Schmid-Wendtner, Walter Burgdorf
Dec 24, 2005·The New England Journal of Medicine·David M NathanUNKNOWN Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research
Jan 31, 2006·Diabetes Care·Catherine L MartinUNKNOWN DCCT/EDIC Research Group

❮ Previous
Next ❯

Citations

Nov 5, 2013·Diabetes Technology & Therapeutics·John C PickupSiobhan Pender
Oct 5, 2013·Diabetes Technology & Therapeutics·Parul J PatelBruce A Buckingham
Apr 5, 2014·Actas dermo-sifiliográficas·E Baselga Torres, M Torres-Pradilla
Feb 18, 2016·Diabetes Technology & Therapeutics·Lutz Heinemann
Apr 14, 2015·Diabetes/metabolism Research and Reviews·Paolo PozzilliEric Renard
Aug 21, 2010·Endocrinology and Metabolism Clinics of North America·Sanjeev N Mehta, Joseph I Wolfsdorf
Jun 21, 2015·Acta Diabetologica·P L RossB J Wheeler
Jan 28, 2009·Diabetes/metabolism Research and Reviews·Daniela BruttomessoAldo Baritussio
May 27, 2016·Diabetes Technology & Therapeutics·Andrew W KarlinBruce Buckingham
Sep 7, 2016·Mayo Clinic Proceedings·Anders H FridKenneth W Strauss
Nov 3, 2016·Case Reports in Pediatrics·Ilan J N KoppenA S Paul van Trotsenburg
Nov 21, 2014·Journal of Diabetes Science and Technology·Olga KordonouriThomas Danne
Jun 2, 2010·Journal of Diabetes Science and Technology·Jean-Louis Selam
Aug 28, 2012·Journal of Diabetes Science and Technology·Lutz Heinemann, Lars Krinelke
Aug 31, 2014·Journal of Diabetes Science and Technology·Lutz HeinemannRoman Hovorka
Jun 20, 2018·Diabetes Technology & Therapeutics·Laurel H MesserGregory P Forlenza
Jul 26, 2018·Diabetes Technology & Therapeutics·Anna Korsgaard BergJannet Svensson
Jan 9, 2019·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Asma DeebKen Strauss
Apr 2, 2019·Journal of Diabetes Science and Technology·Ershuai Zhang, Zhiqiang Cao
Nov 16, 2011·Nature Reviews. Nephrology·Adnan Sharif, Keshwar Baboolal
Dec 14, 2019·American Journal of Therapeutics·Revital NimriMoshe Phillip
Jul 18, 2018·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Haya Abu GhazalehHenrietta Mulnier
Jan 19, 2017·Diabetes Technology & Therapeutics·Linong JiLaurence J Hirsch
Apr 30, 2017·Journal of Endocrinological Investigation·F BertuzziO Epis
Mar 16, 2017·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Sanjay KalraKenneth W Strauss
Feb 28, 2018·Pediatric Diabetes·Anna Korsgaard BergJannet Svensson
Nov 15, 2018·Frontiers in Endocrinology·Anjana BarolaDevi Dayal
Nov 11, 2020·Pediatric Dermatology·Victoria A PerezLaura E Levin
Feb 23, 2020·Diabetes Research and Clinical Practice·Fortunato LombardoStefano Passanisi
Mar 12, 2021·ACS Biomaterials Science & Engineering·Swetha Chintala, Simon H Friedman
Jun 30, 2021·Diabetes & Metabolic Syndrome·Sandro GentileUNKNOWN Study Group AMD-OSDI on Injection Technique, and Nefrocenter Research & Nyx Start-up
Oct 9, 2021·Journal of Clinical Nursing·Günay DemirDamla Gökşen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.

Cellulitis

Cellulitis (erysipelas) is a recurring and debilitating bacterial infection of the skin and underlying tissue. Discover the latest research on cellulitis here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Related Papers

BMJ : British Medical Journal
Tahseen A Chowdhury, Valerie Escudier
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [and] German Diabetes Association
K RaileH P Schwarz
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [and] German Diabetes Association
H HaunerB Haastert
© 2022 Meta ULC. All rights reserved